Tata Mutual FundHealthcareDirect plan, growth

Tata India Pharma & Healthcare Fund

Compare healthcare funds Compare with others

NAV: ₹39.24; —11 Sept 2026
AUM (₹ Cr): 1,359; Average, April - June 2026
Expense ratio: 1.06%; Regular 2.37%
Risk: Very High; SEBI riskometer

1Y return: 8.6%-6.8%; Benchmark 15.5%
3Y CAGR: 19.7%-2.9%; Benchmark 22.6%
5Y CAGR: 14.6%-0.2%; Benchmark 14.8%

Loading NAV history…

Tata India Pharma & Healthcare Fund

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
Fund	-1.8%	+6.0%	+15.0%	+11.0%	+8.6%	+19.7%	+14.6%	+14.7%	+13.6%
BSE Healthcare TRI	—	—	—	—	15.5%	22.6%	14.8%	12.7%	11.6%
Healthcare average	0.3%	9.6%	22.5%	20.0%	17.6%	21.7%	15.6%	15.0%	19.1%
Difference	—	—	—	—	-6.8%	-2.9%	-0.2%	+2.1%	+2.0%

Portfolio

Fund details

Fund house: Tata Mutual Fund
Category: Equity · Healthcare
SEBI classification: Equity / Sectoral / Thematic
Benchmark: BSE Healthcare TRI
Launch date: 29 Dec 2015 (10.7 years)
Structure: Open Ended
Plans and options: Direct Growth, Regular Growth
Fund manager: Rajat Srivastava
Minimum SIP: ₹100
Minimum lumpsum: ₹5,000 (then ₹1,000)
Exit load: 0.25%
Lock-in: None
Riskometer: Very High (benchmark Very High)
Expense ratio as of: 9 Sept 2026
AUM period: April - June 2026
ISIN, Direct Growth: INF277K019A3
ISIN, Regular Growth: INF277K016A9
Scheme code: 135810, 135812

NAV and returns as of 11 Sept 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other healthcare funds

Other funds in the Healthcare category.

Compare healthcare funds